Device Trial Radar · NCT07100522
Clinical Evaluation of the Nuance Audio Hearing Aid in Adults With Mild to Moderate Hearing Difficulties
Last checked: Nov 20, 2026Latest source record: Sep 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
21
Actual
Start
Jun 11, 2025
Primary completion
Aug 28, 2025
Study completion Aug 28, 2025
Sponsor
- Lead sponsor
- Luxottica Group S.p.A.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 3, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The research will produce clinical effectiveness performance metrics using standardised procedures of the Nuance Audio hearing device.
Conditions
- Hearing Impairment
Interventions
Hearing aid in spectacle frame form factorDevice
eyewear frames embedded with groundbreaking technology which seamlessly integrate an air conduction hearing aid (over-the-counter "OTC", in the United States) intended to amplify sound for adult users (18yrs and older) with a perceived mild to moderate hearing impairment. Nuance Audio Glasses may, if necessary, be used in association with prescription lenses for those adults who also require correction of visual defects. Nuance Audio Glasses can be worn all day and can be easily configured via the App to adapt to any situation, from business meetings to family time.
hearing aidDevice
Hearing aid in spectacle frame form factor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Speech intellegibility testing (Matrix test) with and without deviceTime frame: Day 1
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Acoustic Laboratories
Macquarie Park, New South Wales, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.